There are 200 million people worldwide with cardiac symptoms. The severity and frequency of these symptoms are not always indicative of the potential associated risk. However, swift action is needed if critical cardiac events occur. Individuals are often on their own to decide what may be a serious event and what to do about it. Capturing a symptomatic event when it occurs and providing individuals with a profound medical trigger to act when a serious event strikes lie at the heart of our enterprise. The founders created Personal MedSystems in 2008 to bring their idea of a small, smartphone-based, but uniquely profound, ECG device with a trigger to act to life: CardioSecur.

There are 200 million people worldwide with cardiac symptoms. The severity and frequency of these symptoms are not always indicative of the potential associated risk. However, swift action is needed if critical cardiac events occur. Individuals are often on their own to decide what may be a serious event and what to do about it. Capturing a symptomatic event when it occurs and providing individuals with a profound medical trigger to act when a serious event strikes lie at the heart of our enterprise. The founders created Personal MedSystems in 2008 to bring their idea of a small, smartphone-based, but uniquely profound, ECG device with a trigger to act to life: CardioSecur.

AliveCor, a leading medical device and AI company, offers FDA-cleared KardiaMobile devices for accurate EKG results at home. Transforming cardiological care with clinically validated personal ECG solutions and AI technology.

AliveCor, a leading medical device and AI company, offers FDA-cleared KardiaMobile devices for accurate EKG results at home. Transforming cardiological care with clinically validated personal ECG solutions and AI technology.